☰

Dan Ilkovitch, Ph.D. - Publications

Affiliations: 
2009 University of Miami, Coral Gables, FL 
Area:
Immunology
Tree Info Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Vincek V, Kallis P, Vause A, Vincek E, Ilkovitch D, Motaparthi K. Cutaneous solitary fibrous tumor: report of three cases with review of histological mimics. Journal of Cutaneous Pathology. PMID 34569103 DOI: 10.1111/cup.14138  0.358
2018 Sanchez IM, Ilkovitch D. A case of a glomus tumor presenting as an atypical hyperkeratotic papule of the hypothenar palm. Jaad Case Reports. 4: 38-40. PMID 29296650 DOI: 10.1016/j.jdcr.2017.10.006  0.441
2013 Ilkovitch D, Carrio R, Lopez DM. Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1. Immunologic Research. 57: 70-80. PMID 24222275 DOI: 10.1007/S12026-013-8451-6  0.638
2012 Ilkovitch D, Carrio R, Lopez DM. uPA and uPA-receptor are involved in cancer-associated myeloid-derived suppressor cell accumulation. Anticancer Research. 32: 4263-70. PMID 23060546  0.665
2011 Ilkovitch D. Role of immune-regulatory cells in skin pathology. Journal of Leukocyte Biology. 89: 41-9. PMID 20628065 DOI: 10.1189/Jlb.0410229  0.457
2009 Hanson EM, Clements VK, Sinha P, Ilkovitch D, Ostrand-Rosenberg S. Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 183: 937-44. PMID 19553533 DOI: 10.4049/Jimmunol.0804253  0.534
2009 Ilkovitch D, Lopez DM. The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression. Cancer Research. 69: 5514-21. PMID 19549903 DOI: 10.1158/0008-5472.Can-08-4625  0.661
2009 Handel-Fernandez ME, Ilkovitch D, Iragavarapu-Charyulu V, Herbert LM, Lopez DM. Decreased levels of both Stat1 and Stat3 in T lymphocytes from mice bearing mammary tumors. Anticancer Research. 29: 2051-8. PMID 19528464  0.658
2009 Torroella-Kouri M, Silvera R, Rodriguez D, Caso R, Shatry A, Opiela S, Ilkovitch D, Schwendener RA, Iragavarapu-Charyulu V, Cardentey Y, Strbo N, Lopez DM. Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated. Cancer Research. 69: 4800-9. PMID 19458073 DOI: 10.1158/0008-5472.Can-08-3427  0.624
2009 Ilkovitch D, Lopez DM. Urokinase-mediated recruitment of myeloid-derived suppressor cells and their suppressive mechanisms are blocked by MUC1/sec. Blood. 113: 4729-39. PMID 19196663 DOI: 10.1182/Blood-2008-08-176438  0.709
2008 Ilkovitch D, Lopez DM. Immune modulation by melanoma-derived factors. Experimental Dermatology. 17: 977-85. PMID 18643844 DOI: 10.1111/J.1600-0625.2008.00779.X  0.646
2008 Ilkovitch D, Handel-Fernandez ME, Herbert LM, Lopez DM. Antitumor effects of Mucin 1/sec involves the modulation of urokinase-type plasminogen activator and signal transducer and activator of transcription 1 expression in tumor cells. Cancer Research. 68: 2427-35. PMID 18381451 DOI: 10.1158/0008-5472.Can-07-5651  0.695
2004 Ilkovitch D, Ostrand-Rosenberg S. MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain. Cancer Immunology, Immunotherapy : Cii. 53: 525-32. PMID 14730400 DOI: 10.1007/S00262-003-0486-4  0.392
Show low-probability matches.